CCL5, C-C motif chemokine ligand 5, 6352

N. diseases: 514; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders
0.010 AlteredExpression group BEFREE Elevated levels of pro-inflammatory RANTES or MCP-1 and decreased levels of anti-inflammatory IL-10 were found to associate with Parkinsonism and a more rapid disease progression, indicated by longitudinal measurements of either MMSE or ADCS-ADL decline. 31559531 2020
CUI: C0747845
Disease: early pregnancy
early pregnancy
0.010 Biomarker phenotype BEFREE In the present study, we described the potential role of porcine CCL5 in embryo implantation and fetal-maternal environment during early pregnancy. 31563460 2020
CUI: C0001430
Disease: Adenoma
Adenoma
0.010 GeneticVariation group BEFREE We identified that tumor-derived cytokine CCL5 is upregulated in AIP-mutation-positive human adenomas. 30867568 2019
CUI: C0002895
Disease: Anemia, Sickle Cell
Anemia, Sickle Cell
0.010 AlteredExpression disease BEFREE In addition, levels of IP-10 were higher in pregnant women with sickle cell disease and, interestingly, RANTES levels were higher in normal pregnancy when compared to pregnancy in sickle cell disease. 30006250 2019
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.010 Biomarker disease BEFREE Apolipoprotein A-II was also associated with FSS (P = .022). sNfL, CCL5, CCL18, sICAM-1, and sVCAM-1 levels were not associated with fatigue after adjusting for disability and depression. 31307953 2019
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.010 Biomarker disease BEFREE Apolipoprotein A-II was also associated with FSS (P = .022). sNfL, CCL5, CCL18, sICAM-1, and sVCAM-1 levels were not associated with fatigue after adjusting for disability and depression. 31307953 2019
CUI: C0015672
Disease: Fatigue
Fatigue
0.010 AlteredExpression phenotype BEFREE Apolipoprotein A-II was also associated with FSS (P = .022). sNfL, CCL5, CCL18, sICAM-1, and sVCAM-1 levels were not associated with fatigue after adjusting for disability and depression. 31307953 2019
Fibrodysplasia Ossificans Progressiva
0.010 AlteredExpression disease BEFREE There appeared a rather clear-cut signal of a 2-fold higher level of CCL5 in the FOP patient vs. the healthy subject and the van Buchem patient. 31443758 2019
CUI: C0018801
Disease: Heart failure
Heart failure
0.010 Biomarker disease BEFREE ASB14 may be involved in HF progression via protein ubiquitination and CCL5 may be involved in HF via the IRF1-CCL5 interaction. 30370655 2019
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.010 Biomarker disease BEFREE ASB14 may be involved in HF progression via protein ubiquitination and CCL5 may be involved in HF via the IRF1-CCL5 interaction. 30370655 2019
CUI: C0019100
Disease: Severe Dengue
Severe Dengue
0.010 Biomarker disease BEFREE An elevated levels of cytokines IL6 and IL10 chemokine IL8 and CXCL10 along with decreased RANTES were found in the patients with Severe Dengue as compared to mild forms of dengue (p < 0.0001) during 3-6 days of infections. 30395811 2019
CUI: C0022660
Disease: Kidney Failure, Acute
Kidney Failure, Acute
0.010 Biomarker disease BEFREE Compared to wild-type (WT) mice with a renal IRI, IL-10 knockout (IL-10 KO) mice with IRI demonstrated decreased renal function as represented by blood urea nitrogen and serum creatinine, upregulated early acute kidney injury (AKI) biomarkers such as kidney injury molecule-1 (Kim-1), increased mRNA expression of the pro-inflammatory cytokines IL-1β, IL-6, and IL-18 and a chemokine (regulated on activation, normal T cell expressed and secreted; RANTES), and increased expression of the pro-apoptosis factors Bax and cleaved caspase-3. 30700847 2019
CUI: C0032302
Disease: Mycoplasma pneumonia
Mycoplasma pneumonia
0.010 Biomarker disease BEFREE These results indicated that CCL5 may be involved in the progression of MPP, and hyperoside was beneficial for MPP probably through CCL5-CCR4 interactions, which may provide a potential effective therapy for MPP. 30350306 2019
CUI: C0034068
Disease: Pulmonary Eosinophilia
Pulmonary Eosinophilia
0.010 Biomarker disease BEFREE Although several chemokines, including eotaxin-1 (CCL11), RANTES (CCL5) and macrophage inflammatory protein 1β (MIP-1β or CCL4), have been detected in bronchoalveolar lavage fluid (BALF) from patients with EP, the pathophysiological mechanisms underlying EP, including potential relationships between eosinophils and CCL4, have not been fully elucidated. 30854716 2019
CUI: C0040034
Disease: Thrombocytopenia
Thrombocytopenia
0.010 AlteredExpression phenotype BEFREE Even though the degree of thrombocytopenia and platelet activation were similar between dengue-infected and HIV plus dengue-coinfected patients, plasma levels of the platelet-derived chemokines RANTES/CCL5 and PF4/CXCL4 were lower in coinfection. 31068600 2019
CUI: C0041912
Disease: Upper Respiratory Infections
Upper Respiratory Infections
0.010 Biomarker group BEFREE NOP children had higher levels of IL-6 (P = .02), IL-10 (P = .02), interferon-γ (P = .003), TNF-α (P = .006), IL-1β (P = .022), monocyte chemoattractant protein 1 (P = .028), RANTES (P = .005), IL-2 (P = .002), and IL-17 (P = .007) during viral URIs versus AOMs following the URIs, when compared to sOP children. 30188973 2019
CUI: C0151517
Disease: Complete atrioventricular block
Complete atrioventricular block
0.010 AlteredExpression disease BEFREE Increasing serum level of CCL5 in CHB patients was severely associated with disease progression. 31200663 2019
CUI: C0151846
Disease: Periosteal Disorder
Periosteal Disorder
0.010 Biomarker disease BEFREE Thus, the adult periosteum maintains genetically distinct SSC subsets with a CCL5-dependent migratory mechanism required for bone maintenance and injury repair. 31809737 2019
Ki-1+ Anaplastic Large Cell Lymphoma
0.010 AlteredExpression disease BEFREE In patients with ALK<sup>-</sup> anaplastic large cell lymphoma, 9 cytokines showed a prognostic impact, with higher levels of interferon γ, interleukin (IL)-8, IL-10, IL-17, IL-23, IP-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-1β, and RANTES negatively affecting clinical outcomes. 30327172 2019
CUI: C0235989
Disease: Renal interstitial fibrosis
Renal interstitial fibrosis
0.010 Biomarker disease BEFREE Besides, their gene expression levels were found significantly positive correlation with the degree of RIF (CD2: P<0.05, r=0.29; CCL5: P<0.05, r=0.31; CCR5: P<0.05, r=0.38). 31700890 2019
CUI: C0243010
Disease: Viral Encephalitis
Viral Encephalitis
0.010 Biomarker group BEFREE CCL2 and CCL5 along with TLR7 may be associated with degree of pathogenesis of JE and could be putative therapeutic targets for preventing severe inflammation during viral encephalitis. 30585774 2019
CUI: C0275524
Disease: Coinfection
Coinfection
0.010 Biomarker phenotype BEFREE Even though the degree of thrombocytopenia and platelet activation were similar between dengue-infected and HIV plus dengue-coinfected patients, plasma levels of the platelet-derived chemokines RANTES/CCL5 and PF4/CXCL4 were lower in coinfection. 31068600 2019
CUI: C0276289
Disease: Zika Virus Infection
Zika Virus Infection
0.010 Biomarker disease BEFREE A total of 125 Vero cell host proteins, including cytokines such as CXCL11 and CCL5, interferon stimulated gene 15, and translation initiation factors EIF5A and EIF4G2, are significantly dysregulated after ZIKV infection. 30578658 2019
CUI: C0279628
Disease: Adenocarcinoma Of Esophagus
Adenocarcinoma Of Esophagus
0.010 Biomarker disease BEFREE Despite the abundance of Th1 chemokines RANTES (CCL5) and MIP-1α (CCL3) in OAC tumour, enrichments of intratumoural T cells expressing corresponding receptors were not observed. 30834503 2019
CUI: C0333983
Disease: Hyperplastic Polyp
Hyperplastic Polyp
0.010 AlteredExpression disease BEFREE In vitro, M. pneumoniae (MP) infection to A549 cells induced the expression of CCL5, chemokines receptor 4 (CCR4), nuclear factor-κB (NF-κB) nuclear protein, and phosphorylation of NF-κB-p65 (p-NF-κB-p65), whereas NF-κB cytoplasmic protein was decreased. 30350306 2019